Clinical trial
Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia in Preterm Infants
NCT01503801 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia in Preterm Infants
- Lead sponsor
- Fudan University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- May 31, 2011
- Completion date
- December 31, 2012
- Enrollment
- 400 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pulmonary disease